PFBT
IBRX icon

Parkside Financial Bank & Trust’s ImmunityBio IBRX Stock Holding History

Parkside Financial Bank & Trust’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.45K Hold
280
– – ﹤0.01% 2110
2026
Q1 		$2.14K Hold
280
– – ﹤0.01% 2091
2025
Q4 		$555 Buy
+280
New +$634 ﹤0.01% 2553
2025
Q2 		– Sell
-175
Closed -$527 – 2863
2025
Q1 		$527 Buy
+175
New +$530 ﹤0.01% 2348

Other funds holding IBRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Parkside Financial Bank & Trust's IBRX Position: Q2 2026 in Review

Parkside Financial Bank & Trust held its ImmunityBio (IBRX) position steady in Q2 2026 at 280 shares worth $2.45K. The position accounts for ﹤0.01% of the portfolio, ranked #2110.

Parkside Financial Bank & Trust first reported a position in IBRX in Q1 2025 and has held it in 4 quarters since. 405 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

  • Parkside Financial Bank & Trust held 280 shares of ImmunityBio worth $2.45K as of Q2 2026.
  • Parkside Financial Bank & Trust left its ImmunityBio share count unchanged in Q2 2026.
  • ImmunityBio made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #2110 holding.
  • Parkside Financial Bank & Trust first reported a position in ImmunityBio in Q1 2025 and has held it in 4 quarters since.
  • 405 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.